Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years

If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)

Leslie E. Donato net worth and biography

Leslie Donato Biography and Net Worth

EVP of Cencora

Leslie Donato is Executive Vice President and Chief Strategy Officer for AmerisourceBergen Corporation. In this role, she architects and leads the organization’s long-term growth strategy and oversees initiatives that aim to diversify the organization’s portfolio through innovative build or buy opportunities.

Ms. Donato has over 25 years of long-range strategy and healthcare industry expertise. Prior to being named to her current role, she was the Vice President of Strategy at Bayer Pharmaceuticals. Over the course of her career at Bayer, she led the US Business Unit for Hematology and Neurology and the global strategic marketing function for neurology.

Prior to these roles, Ms. Donato was a principal and founding partner of McKinsey & Company’s Philadelphia office. Over the course of her 14-year tenure with McKinsey & Company, she helped healthcare company executives improve performance across strategy, organization re-design and capability building, commercial excellence including brand strategy and sales force architecture and business development. While there, she also led the Mid-Atlantic office women’s initiative, responsible for attracting, developing and retaining talented female consultants. She started her career at Deloitte Consulting.

Ms. Donato graduated from Swarthmore College with a Bachelors of Arts with Distinction in Economics and Public Policy and received her Master of Business Administration from The Wharton School at the University of Pennsylvania.

What is Leslie E. Donato's net worth?: The estimated net worth of Leslie E. Donato is at least $2.05 million as of December 21st, 2023. Ms. Donato owns 8,519 shares of Cencora stock worth more than $2,052,057 as of April 28th. This net worth estimate does not reflect any other investments that Ms. Donato may own. Learn More about Leslie E. Donato's net worth.
How old is Leslie E. Donato?: Ms. Donato is currently 54 years old. There are 7 older executives and no younger executives at Cencora. The oldest executive at Cencora is Ms. Gina K. Clark, Executive VP and Chief Communications & Administration Officer, who is 67 years old. Learn More on Leslie E. Donato's age.
How do I contact Leslie E. Donato?: The corporate mailing address for Ms. Donato and other Cencora executives is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. Cencora can also be reached via phone at (610) 727-7000 and via email at [email protected]. Learn More on Leslie E. Donato's contact information.
Has Leslie E. Donato been buying or selling shares of Cencora?: Leslie E. Donato has not been actively trading shares of Cencora during the last ninety days. Most recently, Leslie E. Donato sold 3,400 shares of the business's stock in a transaction on Thursday, December 21st. The shares were sold at an average price of $202.13, for a transaction totalling $687,242.00. Following the completion of the sale, the executive vice president now directly owns 8,519 shares of the company's stock, valued at $1,721,945.47. Learn More on Leslie E. Donato's trading history.
Who are Cencora's active insiders?: Cencora's insider roster includes Silvana Battaglia (EVP), Elizabeth Campbell (EVP), John Chou (EVP), Gina Clark (EVP), Gina Clark (EVP), Steven Collis (CEO), Leslie Donato (EVP), Leslie Donato (EVP), Jeffrey Finnin (CFO), Juan Font (SVP), Jane Henney, MD (Director), Mark Jones (CAO), Maile Kaiser (SVP), Michael Koehler (Director), Lazarus Krikorian (CAO), Aleksandra Krusko (SVP), Robert Mauch (EVP), Robert Mauch (COO), Derek McCandless (SVP), Henry McGee, III (Director), Steven Smith (CRO), Paul Szurek (CEO), and Brian Warren (SVP). Learn More on Cencora's active insiders.
Are insiders buying or selling shares of Cencora?: During the last year, insiders at the sold shares 21 times. They sold a total of 7,622,034 shares worth more than $1,640,810,686.31. The most recent insider tranaction occured on April, 16th when CEO Steven H Collis sold 10,754 shares worth more than $2,553,859.92. Insiders at Cencora own 15.8% of the company. Learn More about insider trades at Cencora.
Information on this page was last updated on 4/16/2024.

Leslie E. Donato Insider Trading History at Cencora

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/21/2023	Sell	3,400	$202.13	$687,242.00	8,519
11/13/2023	Sell	3,387	$197.60	$669,271.20	11,919
12/9/2022	Sell	3,014	$166.12	$500,685.68	6,984

Leslie E. Donato Buying and Selling Activity at Cencora

Cencora Company Overview

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Today's Range

Now: $240.88

$238.10

$241.36

50 Day Range

MA: $238.55

$231.72

$245.77

2 Week Range

Now: $240.88

$163.37

$246.75

Volume

972,783 shs

Average Volume

1,039,289 shs

Market Capitalization

$48.05 billion

P/E Ratio

26.24

Dividend Yield

0.85%

Beta

0.45

Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years

From Banyan Hill Publishing | Ad

If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)

Watch my video for all of the details

Leslie Donato Biography and Net Worth

What is Leslie E. Donato's net worth?

How old is Leslie E. Donato?

How do I contact Leslie E. Donato?

Has Leslie E. Donato been buying or selling shares of Cencora?

Who are Cencora's active insiders?

Are insiders buying or selling shares of Cencora?